NORCROSS,Immucor has sold its first automated instrument-reagent system for the blood transfusion industry in the US, the company said Monday.
The buyer is the Henry Ford Health System, based in Detroit.
Immucor’s Galileo system will be used for blood grouping, blood typing, antibody screening, antibody identification and crossmatch.
Immucor: www.immucor.com
